Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer ImmunotherapyAurélie Durgeau, Fathia Mami‐Chouaib|Frontiers in Immunology|2018Cited by 513
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Fabien Lemaître et al.|Science|2020Cited by 382
Resident memory T cells, critical components in tumor immunologyFathia Mami‐Chouaib, Éric Tartour|Journal for ImmunoTherapy of Cancer|2018Cited by 333
The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 IntegrinStéphanie Corgnac, Fathia Mami‐Chouaib|Frontiers in Immunology|2018Cited by 161
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1Marine Leclerc, Fathia Mami‐Chouaib|Nature Communications|2019Cited by 144